Lenalidomide in the treatment of multiple myeloma: a review.
about
Evidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaLenalidomide in multiple myeloma: current experimental and clinical data.Radical-mediated dehydrative preparation of cyclic imides using (NH4)2S2O8-DMSO: application to the synthesis of vernakalant.Lenalidomide (Revlimid): A Thalidomide Analogue in Combination With Dexamethasone For the Treatment of All Patients With Multiple Myeloma.The chemistry of isoindole natural products.Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma.Lenalidomide and thalidomide in the treatment of chronic pain.Lenalidomide-induced diffuse alveolar hemorrhage.Antiproliferative and antibacterial activity of some glutarimide derivatives.DNA methyltransferase inhibitors: an updated patent review (2012-2015).Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating
P2860
Q26823292-4DDA6363-A768-4707-8C22-035833D3FEDAQ34074803-88B0CABA-FE12-4FE6-B9EC-D6D7303FAEEAQ35859643-D2F7B236-2128-4642-BC23-CDDCDF25774CQ36848023-0B2F145E-8109-4BE5-8FB7-33C805DDA814Q37279822-8F9BF435-ACCF-4884-8732-9AB238411EFAQ37535101-25959E0E-571D-4D57-B957-324DBCAC17F0Q38031989-3ED4DD2A-AFBC-4014-ADAC-EAAA663E6E5BQ38084729-1DC1A857-E000-4A4C-AC0C-25FB482BBB8CQ38368599-0B103976-6CFC-4F76-8814-E86057009EF7Q38845989-1609C1E7-33B6-4864-8F30-4C5876363939Q38885370-86E6FA22-BAFE-4664-9115-F5978769A828Q39524467-58CD3251-43C9-493C-A59A-61BD2EA66D5BQ39627268-214DE4A6-A025-4431-BD94-71BF7B43D1D1Q39697464-38398D06-AF7B-445E-A230-029A79318A0EQ50543689-02898EAB-8B9F-48E1-A147-CB1D63361972
P2860
Lenalidomide in the treatment of multiple myeloma: a review.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Lenalidomide in the treatment of multiple myeloma: a review.
@ast
Lenalidomide in the treatment of multiple myeloma: a review.
@en
Lenalidomide in the treatment of multiple myeloma: a review.
@nl
type
label
Lenalidomide in the treatment of multiple myeloma: a review.
@ast
Lenalidomide in the treatment of multiple myeloma: a review.
@en
Lenalidomide in the treatment of multiple myeloma: a review.
@nl
prefLabel
Lenalidomide in the treatment of multiple myeloma: a review.
@ast
Lenalidomide in the treatment of multiple myeloma: a review.
@en
Lenalidomide in the treatment of multiple myeloma: a review.
@nl
P2093
P2860
P1476
Lenalidomide in the treatment of multiple myeloma: a review.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2710.2008.00920.X
P577
2008-06-01T00:00:00Z